IDR 1002 is a synthetic cationic innate defense regulator peptide.1 It increases the production of chemokine (C-C motif) ligand 2 (CCL2), CCL7, and chemokine (C-X-C motif) ligand 1 (CXCL1) in isolated human peripheral blood mononuclear cells (PBMCs) when used at a concentration of 100 µg/ml. IDR 1002 (200 µg/animal) increases the numbers of neutrophils and monocytes in mouse peritoneum and protects against S. aureus and E. coli infections in mice.
1.Nijnik, A., Madera, L., Ma, S., et al.Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitmentJ. immunol.184(5)2539-2550(2010)
















